Human Trials Of Ebola Vaccine To Start Next Week
"There is an urgent need for a protective Ebola vaccine, and it is important to establish that a vaccine is safe and spurs the immune system to react in a way necessary to protect against infection," NIAID director Anthony Fauci said in a press release.
GSK said in a statement that the British consortium that also involved the British government has pledged some $4.6 million for the phase one trials, which are expected to be completed by the end of 2014.
According to the World Health Organisation, at least 1,552 suspected and confirmed deaths from Ebola infection have been reported in Guinea, Liberia, Nigeria, and Sierra Leone since the outbreak of the deadly virus was first reported in March 2014.
Read More: Celebrities Replaced By Products For Endorsements and The 10 Most World-Changing Ads
